Custom synthesis and contract manufacturing for the chemical and pharmaceutical industries, focusing on high energetic and hazardous chemistry. Production of advanced intermediates and active pharmaceutical ingredients.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
EmpCo Directive — September 27, 2026
We analyzed the websites of over 250,000 companies, including Valsynthese's, to extract CSR initiatives and communications containing risky environmental claims.
Greenwashing risk score + your position within your sector
+250,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: July 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Interor
B
Manufacturing of advanced organic intermediates for pharmaceutical, cosmetic, and specialty chemical industries. Provides custom manufacturing, R&D, and process development services.
Seqens
A
Manufacturing pharmaceutical ingredients, personal care products, and specialty chemicals. Developing custom specialty ingredients and high-quality specialized chemical products.
Alzchem Group
B
Specialty chemicals production, including dietary supplements, pharmaceutical raw materials, and creatine-based products for human and animal nutrition, agriculture, and health.
Initiatives identified among leaders
Solvants biosourcés pour une chimie durable et performante
“Seqens propose une gamme de solvants biosourcés dé...” - SeqensRenforcement des pratiques sécurité et santé pour les employés en 2022.
“Interor a renouvelé son adhésion à la Charte Respo...” - InterorExclusion de substances chimiques nocives dans la production de peptides.
“SEQENS exclut l'utilisation de **TFA (acide triflu...” - Seqens74% of similar organizations communicate on CSR issues
+712 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports